Tilray Stock: Risky Growth Stock or Value Pick?

Is Tilray stock a reasonable bet long-term investors should think about making right now, or is this stock too risky to buy right now?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis sector is a fast-growing one, expected to see worldwide sales really $176 billion by 2030. For investors in Tilray (TSX:TLRY)(NASDAQ:TLRY) stock, this growth has been the key investment thesis for some time.

However, actual growth rates in Canada for marijuana sales have underperformed of late. Previous excesses in the valuation of cannabis stocks have led to quite the downturn for Tilray. Today, Tilray stock trades at a small fraction of its previous high, down well more than 90% from its peak.

Will growth investors return to the cannabis sector? And if so, will Tilray stock be one investors pick? Let’s dive in.

Tilray posts positive net income, pushing for more market share

Well, there’s some good news for investors look at Tilray stock from a fundamentals standpoint.

Earlier this month, Tilray announced its earnings. The company posted a net income of roughly US$6 million in its latest quarter in comparison with a net loss of approximately US$89 million in the same quarter in 2021. The organization stated that its net income for the quarter that ended on November 30 broke even on a per-share basis. As a reference, the same quarter of 2021 saw a loss of $0.41 per share.

These solid numbers did boost Tilray stock 15% immediately following these results. However, since the earnings report, Tilray has seen selling, as recent macro headwinds hit growth stocks hard. The potential for rising interest rates has investors in more speculative areas cautious, leading to valuation compression among companies like Tilray.

That said, investors looking for growth may like Tiray’s push into the hemp market and CBD-infused beverage market. Clearly a risky pick, Tilray stock is one that has inspired near-term rallies some retail investors may be enamoured by.

More positives for Tilray stock

Investors should also remember that Tilray has made some acquisitions to broaden its portfolio. The company recently bought SweetWater Brewing and Breckenridge Distillery to deliver growth in the beverage category. Also, Tilray purchased Manitoba Harvest to drive its market share in consumer packaged goods.

To reflect its transition from a Canada based licensed cannabis producer to a global consumer packaged goods organization, Tilray has planned to use Tilray Brands Inc. as its new parent brand name.

Tilray Brands is looking forward to growing its presence in the United States and internationally. Along with all its growth opportunities, the company anticipates producing annual revenue of $4 billion by fiscal 2024. Now that’s a substantial jump! 

Bottom line

The reality is that the market is taking a risk-off approach right now. Tilray, once a meme stock (before the term was “cool” by WallStreetBets standards), has seen its share of surges in the past. However, shifting investor sentiment away from growth and toward value could hamper this stock in the near term.

That said, these recent results are a positive. Perhaps Tilray stock is a decent pickup at these levels. Time will tell.

For now, I remain on the sidelines with respect to Tilray due to its risk profile.

Should you invest $1,000 in Enbridge right now?

Before you buy stock in Enbridge, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Enbridge wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »